Approval · Notice of Compliance 36518 · 2025
PLENDIL: Notice of Compliance 36518
Issued December 9, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 36518
- Date
- December 9, 2025
- Company
- Glenwood Gmbh Pharmazeutische ErzeugnisseMunich, --, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PLENDIL | Not yet assigned | — |
Medicinal ingredients
- FELODIPINE 2.5 MG per TAB
- FELODIPINE 5 MG per TAB
- FELODIPINE 10 MG per TAB